(Reuters) - Mylan NV said it would launch the first generic version of its allergy auto-injector EpiPen for $300 (229 pounds), half the price of the branded product, the drugmaker's second step in ...
(Reuters) - Mylan NV said it would launch the first generic version of its allergy auto-injector EpiPen for $300, half the price of the branded product, the drugmaker's second step in less than a week ...
A U.S. regulator this week told Pfizer Inc’s Meridian Medical Technologies division, maker of the EpiPen injector device, that serious component and product failures have been associated with patient ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する